100 related articles for article (PubMed ID: 26729195)
1. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.
Zhu B; Wei Y
Cancer Med; 2020 Jan; 9(2):783-796. PubMed ID: 31957323
[TBL] [Abstract][Full Text] [Related]
3. The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1.
Ning F; Du L; Li J; Wu T; Zhou J; Chen Z; Hu X; Zhang Y; Luan X; Xin H; Yuan C; Zhang X
Life Sci; 2024 Jul; 348():122674. PubMed ID: 38692507
[TBL] [Abstract][Full Text] [Related]
4. BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner.
Liu Z; Hu C; Zheng L; Liu J; Li K; Li X; Wang Y; Mu W; Chen T; Shi A; Qiu B; Zhang X; Zhang Z; Xu Y
Cell Mol Life Sci; 2022 Aug; 79(9):469. PubMed ID: 35932322
[TBL] [Abstract][Full Text] [Related]
5. High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.
Zhang ZF; Zhang HR; Zhang QY; Lai SY; Feng YZ; Zhou Y; Zheng SR; Shi R; Zhou JY
J Transl Med; 2018 Jan; 16(1):9. PubMed ID: 29351801
[TBL] [Abstract][Full Text] [Related]
6. FUT4 promotes the progression of Cholangiocarcinoma by modulating epithelial-mesenchymal transition.
Liu E; Qian X; He Y; Chen K
Cell Cycle; 2024 Jan; 23(2):218-231. PubMed ID: 38466946
[TBL] [Abstract][Full Text] [Related]
7. Recruited metastasis suppressor NM23-H2 attenuates expression and activity of peroxisome proliferator-activated receptor δ (PPARδ) in human cholangiocarcinoma.
He F; York JP; Burroughs SG; Qin L; Xia J; Chen D; Quigley EM; Webb P; LeSage GD; Xia X
Dig Liver Dis; 2015 Jan; 47(1):62-7. PubMed ID: 25277864
[TBL] [Abstract][Full Text] [Related]
8. DCLK1 Expression and its Functional Significance in Intrahepatic Cholangiocarcinoma and Bil-IN Stage.
Fukushima NM; Adachi T; Tanaka T; Matsushima H; Imamura H; Hara T; Soyama A; Hidaka M; Kanetaka K; Eguchi S
Anticancer Res; 2024 Jun; 44(6):2417-2424. PubMed ID: 38821583
[TBL] [Abstract][Full Text] [Related]
9. Circ_0007534 promotes cholangiocarcinoma stemness and resistance to anoikis through DDX3X-mediated positive feedback regulation of parental gene DDX42.
Liu S; Guan C; Sha X; Gao X; Zou X; Yang C; Zhang X; Zhong X; Jiang X
Cell Signal; 2024 Jun; 118():111141. PubMed ID: 38492624
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma.
Lewinska M; Zhuravleva E; Satriano L; Martinez MB; Bhatt DK; Oliveira DVNP; Antoku Y; Keggenhoff FL; Castven D; Marquardt JU; Matter MS; Erler JT; Oliveira RC; Aldana BI; Al-Abdulla R; Perugorria MJ; Calvisi DF; Perez LA; Rodrigues PM; Labiano I; Banales JM; Andersen JB
Gastroenterology; 2024 May; 166(5):886-901.e7. PubMed ID: 38096955
[TBL] [Abstract][Full Text] [Related]
11. Bmi1 facilitates the progression of cholangiocarcinoma by inhibiting Foxn2 expression dependent on a histone H2A ubiquitination manner.
Song Y; Lian S; Fan H; Ma C; Zheng L; Huang F; Huang S; Tang Y; Shi A; Shu L; Zhao L; Xu Y; Guo S; Liu Z; Zhang Z
Cancer Lett; 2024 Jun; 592():216921. PubMed ID: 38705565
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells.
Pan S; Hu Y; Gan L; Lai J; Zheng P; Zhang Y; Shuai L; Jiang Y; Chen M; Wang J; He Y
Ann Hepatol; 2024; 29(2):101279. PubMed ID: 38123132
[TBL] [Abstract][Full Text] [Related]
13. The LIM and SH3 domain protein family: structural proteins or signal transducers or both?
Grunewald TG; Butt E
Mol Cancer; 2008 Apr; 7():31. PubMed ID: 18419822
[TBL] [Abstract][Full Text] [Related]
14. Role of Wisteria floribunda agglutinin binding glycans in carcinogenesis and metastasis of cholangiocarcinoma.
Phuyathip W; Putthisen S; Panawan O; Ma-In P; Teeravirote K; Sintusen P; Udomkitkosol S; Detarya M; Luang S; Mahalapbutr P; Sato T; Kuno A; Chuangchaiya S; Silsirivanit A
Histochem Cell Biol; 2024 May; 161(5):423-434. PubMed ID: 38393396
[TBL] [Abstract][Full Text] [Related]
15. The histone lysine acetyltransferase KAT2B inhibits cholangiocarcinoma growth: evidence for interaction with SP1 to regulate NF2-YAP signaling.
Ma W; Zhang J; Chen W; Liu N; Wu T
J Exp Clin Cancer Res; 2024 Apr; 43(1):117. PubMed ID: 38641672
[TBL] [Abstract][Full Text] [Related]
16. FAXC interacts with ANXA2 and SRC in mitochondria and promotes tumorigenesis in cholangiocarcinoma.
Fujimori H; Shima-Nakamura M; Kanno SI; Shibuya-Takahashi R; Mochizuki M; Mizuma M; Unno M; Wakui Y; Abue M; Iwai W; Fukushi D; Satoh K; Yamaguchi K; Shindo N; Yasuda J; Tamai K
Cancer Sci; 2024 Jun; 115(6):1896-1909. PubMed ID: 38480477
[TBL] [Abstract][Full Text] [Related]
17. The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression.
Liu N; Zhang J; Chen W; Ma W; Wu T
J Exp Clin Cancer Res; 2023 Oct; 42(1):263. PubMed ID: 37817227
[TBL] [Abstract][Full Text] [Related]
18. Protein regulator of cytokinesis 1 accentuates cholangiocarcinoma progression via mTORC1-mediated glycolysis.
Zhang C; Qin C
Hum Cell; 2024 May; 37(3):739-751. PubMed ID: 38416277
[TBL] [Abstract][Full Text] [Related]
19. Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies.
Hong JH; Yong CH; Heng HL; Chan JY; Lau MC; Chen J; Lee JY; Lim AH; Li Z; Guan P; Chu PL; Boot A; Ng SR; Yao X; Wee FYT; Lim JCT; Liu W; Wang P; Xiao R; Zeng X; Sun Y; Koh J; Kwek XY; Ng CCY; Klanrit P; Zhang Y; Lai J; Tai DWM; Pairojkul C; Dima S; Popescu I; Hsieh SY; Yu MC; Yeong J; Kongpetch S; Jusakul A; Loilome W; Tan P; Tan J; Teh BT
Gut; 2024 May; 73(6):966-984. PubMed ID: 38050079
[TBL] [Abstract][Full Text] [Related]
20. EIF3B stabilizes PCNA by counteracting SYVN1-mediated ubiquitination to serve as a promotor in cholangiocarcinoma.
Huang R; Nie W; Mi L; Yao C; Zhu H
Aging (Albany NY); 2024 Apr; 16(8):7311-7330. PubMed ID: 38687509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
